174 related articles for article (PubMed ID: 19836370)
21. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
[TBL] [Abstract][Full Text] [Related]
22. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
23. Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease.
Giovannini MG; Cerbai F; Bellucci A; Melani C; Grossi C; Bartolozzi C; Nosi D; Casamenti F
Neuroscience; 2008 May; 153(3):618-33. PubMed ID: 18406062
[TBL] [Abstract][Full Text] [Related]
24. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
[TBL] [Abstract][Full Text] [Related]
25. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
[TBL] [Abstract][Full Text] [Related]
27. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
28. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
29. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?
Richter H; Ambrée O; Lewejohann L; Herring A; Keyvani K; Paulus W; Palme R; Touma C; Schäbitz WR; Sachser N
Behav Brain Res; 2008 Jun; 190(1):74-84. PubMed ID: 18342378
[TBL] [Abstract][Full Text] [Related]
30. Alzheimer's disease selective vulnerability and modeling in transgenic mice.
Götz J; Schonrock N; Vissel B; Ittner LM
J Alzheimers Dis; 2009; 18(2):243-51. PubMed ID: 19584440
[TBL] [Abstract][Full Text] [Related]
31. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
Obulesu M; Rao DM
Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
[TBL] [Abstract][Full Text] [Related]
32. [Animal model for Alzheimer's disease].
Takashima A; Chui D
Nihon Rinsho; 2004 Apr; 62 Suppl 4():240-7. PubMed ID: 15174678
[No Abstract] [Full Text] [Related]
33. Transgenic mouse models of Alzheimer's disease.
Elder GA; Gama Sosa MA; De Gasperi R
Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's disease: old problem, new views from transgenic and viral models.
Jaworski T; Dewachter I; Seymour CM; Borghgraef P; Devijver H; Kügler S; Van Leuven F
Biochim Biophys Acta; 2010 Oct; 1802(10):808-18. PubMed ID: 20332023
[TBL] [Abstract][Full Text] [Related]
35. Animal systems in the development of treatments for Alzheimer's disease: challenges, methods, and implications.
Sabbagh JJ; Kinney JW; Cummings JL
Neurobiol Aging; 2013 Jan; 34(1):169-83. PubMed ID: 22464953
[TBL] [Abstract][Full Text] [Related]
36. 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
Zahs KR; Ashe KH
Trends Neurosci; 2010 Aug; 33(8):381-9. PubMed ID: 20542579
[TBL] [Abstract][Full Text] [Related]
37. Alzheimer's disease modeling: ups, downs, and perspectives for human induced pluripotent stem cells.
Wojda U; Kuznicki J
J Alzheimers Dis; 2013; 34(3):563-88. PubMed ID: 23313930
[TBL] [Abstract][Full Text] [Related]
38. Transgenic animals as models of neurodegenerative diseases in humans.
Theuring F; Thunecke M; Kosciessa U; Turner JD
Trends Biotechnol; 1997 Aug; 15(8):320-5. PubMed ID: 9263480
[TBL] [Abstract][Full Text] [Related]
39. [Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease].
Matsubara E
Nihon Rinsho; 2012 Feb; 70(2):349-52. PubMed ID: 22413544
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease. Mouse model made.
Duff K; Hardy J
Nature; 1995 Feb; 373(6514):476-7. PubMed ID: 7845455
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
